Logo image of OZ

BELPOINTE PREP LLC (OZ) Stock Fundamental Analysis

NYSEARCA:OZ - American Stock Exchange - US0806941029 - Common Stock

61.7  +0.95 (+1.56%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to OZ. OZ was compared to 65 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of OZ have multiple concerns. OZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OZ had negative earnings in the past year.
OZ had a negative operating cash flow in the past year.
OZ Yearly Net Income VS EBIT VS OCF VS FCFOZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -50M -100M -150M

1.2 Ratios

OZ's Return On Assets of -4.00% is in line compared to the rest of the industry. OZ outperforms 45.90% of its industry peers.
The Return On Equity of OZ (-6.42%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4%
ROE -6.42%
ROIC N/A
ROA(3y)-2.28%
ROA(5y)N/A
ROE(3y)-2.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OZ Yearly ROA, ROE, ROICOZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 20 40 60 80 100

1.3 Margins

OZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OZ Yearly Profit, Operating, Gross MarginsOZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

OZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OZ has more shares outstanding
OZ has a worse debt/assets ratio than last year.
OZ Yearly Shares OutstandingOZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1M 2M 3M
OZ Yearly Total Debt VS Total AssetsOZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

A Debt/Equity ratio of 0.48 indicates that OZ is not too dependend on debt financing.
OZ has a Debt to Equity ratio of 0.48. This is comparable to the rest of the industry: OZ outperforms 49.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.99%
OZ Yearly LT Debt VS Equity VS FCFOZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

OZ has a Current Ratio of 0.75. This is a bad value and indicates that OZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.75, OZ is doing worse than 78.69% of the companies in the same industry.
OZ has a Quick Ratio of 0.75. This is a bad value and indicates that OZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.75, OZ is doing worse than 73.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
OZ Yearly Current Assets VS Current LiabilitesOZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for OZ have decreased strongly by -49.22% in the last year.
The Revenue has decreased by -2.92% in the past year.
The Revenue has been growing by 181.54% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-49.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-107.36%
Revenue 1Y (TTM)-2.92%
Revenue growth 3Y181.54%
Revenue growth 5YN/A
Sales Q2Q%83.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OZ Yearly Revenue VS EstimatesOZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 500K 1M 1.5M 2M
OZ Yearly EPS VS EstimatesOZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OZ Price Earnings VS Forward Price EarningsOZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OZ Per share dataOZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BELPOINTE PREP LLC

NYSEARCA:OZ (1/21/2025, 8:19:06 PM)

61.7

+0.95 (+1.56%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners34.9%
Inst Owner Change-2.49%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap231.38M
Analysts0
Price TargetN/A
Short Float %2%
Short Ratio8.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 110.6
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-5.46
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-43.99
FCFYN/A
OCF(TTM)-2.78
OCFYN/A
SpS0.56
BVpS82.31
TBVpS82.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4%
ROE -6.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.28%
ROA(5y)N/A
ROE(3y)-2.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4363.3%
Cap/Sales 7387.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z N/A
F-Score1
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)7464.22%
Cap/Depr(5y)N/A
Cap/Sales(3y)5751.01%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-107.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.92%
Revenue growth 3Y181.54%
Revenue growth 5YN/A
Sales Q2Q%83.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2338.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.93%
OCF growth 3YN/A
OCF growth 5YN/A